Tumor-specific cytotoxic T cells (CTLs) are generated and activated through interaction between the T-cell receptor (TCR) and the major histocompatibility complex (MHC)–peptide complexes expressed on antigen-presenting cells (APCs), including dendritic cells (DCs) and macrophages [72]. Here, HLA-C is linked to neoplasm.